Medicine for treating chronic conjunctivitis

A chronic conjunctivitis and drug technology, applied in the field of drugs for the treatment of chronic conjunctivitis, can solve the problems of complex formula components, not widely used clinically, and insignificant curative effect.

Inactive Publication Date: 2006-02-08
BEIJING INST OF OPHTHALMOLOGY
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The patient feels that the eyes are dry, itchy, and visually fatigued, which seriously affects daily life and study and work. At present, there is no good effective drug in clinical practice. Commonly used antibiotics, vitamin eye drops and astringents are used for treatment, but the curative effect is not significant. Chinese patent disclosure Through some methods of using traditional Chinese medicine to treat conjunctivitis, such as: CN1100953, CN1108556, CN1132627, CN1207322, CN89105757.9, the formulas of these patents have not been successfully used in clinical practice, and the formula components are complicated and the raw materials are expensive
Although the CN02131250.8 patent has simple prescriptions and reasonable compatibility, it has not been widely used clinically so far

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating chronic conjunctivitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] [embodiment 1] preparation of eye drops of medicine of the present invention

[0037]Add 5g of honeysuckle, 5g of astragalus, and 2.5g of Fangfeng, add 20 times of distilled water, decoct and extract twice, each time for 1.5 hours, combine the decoction, filter, and concentrate to a clear liquid with a relative density of 1.10-1.12 (50°C). Paste, add ethanol to precipitate, filter, stand overnight, filter, and recover ethanol from the filtrate under reduced pressure until it has no alcohol smell, add distilled water to adjust the liquid to 12.5ml, and set aside. Crush 0.5g of pearls into powder, add an appropriate amount of water to make a paste, add 1.8 times concentrated hydrochloric acid to hydrolyze to dissolve, let stand for stratification, filter, and then heat the filter residue with 15% hydrochloric acid to reflux for 24 hours, filter the hydrolyzate, combine the two The secondary hydrolyzate was heated in a water bath to drive out the acid, then the pH was adju...

Embodiment 2

[0038] [embodiment 2] eye ​​ointment preparation of medicine of the present invention

[0039] Add 5g of honeysuckle, 5g of astragalus, and 2.5g of Fangfeng, add 20 times of distilled water, decoct and extract twice, each time for 1.5 hours, combine the decoction, filter, and concentrate to a clear liquid with a relative density of 1.10-1.12 (50°C). Paste, add ethanol to precipitate, filter, stand overnight, filter, and recover ethanol from the filtrate under reduced pressure until it has no alcohol smell, add distilled water to adjust the liquid to 12.5ml, and set aside. Crush 0.5g of pearls into powder, add an appropriate amount of water to make a paste, add 1.8 times concentrated hydrochloric acid to hydrolyze to dissolve, let stand to separate layers, filter, and then heat the filter residue with 15% hydrochloric acid to reflux for 24 hours, filter the hydrolyzate, and combine the two The secondary hydrolyzate was heated in a water bath to drive out the acid, then the pH w...

Embodiment 3

[0040] [Embodiment 3] Preparation of eye compress of medicine of the present invention

[0041] The preparation method is the same as in Example 1, under aseptic conditions, the liquid is added to the eye patch of non-woven fabric, packed into an aluminum bag and sealed, to obtain final product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for treating chronic conjunctivitis, which is prepared from honeysuckle, astragalus root, ledebouriella root, pearl powder borneo camphor by certain weight ratio. it can be prepared into any of the conventional dosage forms for ophthalmology.

Description

[technical field] [0001] The invention relates to a medicine for treating chronic conjunctivitis, which belongs to the field of traditional Chinese medicine. [Background technique] [0002] Chronic conjunctivitis is a common disease in ophthalmology. In recent years, due to the popularization of computers and the aggravation of air pollution, the incidence of chronic conjunctivitis has increased year by year, and it has become the most common eye disease in ophthalmology. The patient feels that the eyes are dry, itchy, and visually fatigued, which seriously affects daily life and study and work. At present, there is no good effective drug in clinical practice. Commonly used antibiotics, vitamin eye drops and astringents are used for treatment, but the curative effect is not significant. Chinese patent disclosure Through some methods of using Chinese medicines to treat conjunctivitis, such as: CN1100953, CN1108556, CN1132627, CN1207322, CN89105757.9, the prescriptions of thes...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/481A61K9/00A61P1/00A61K35/618
Inventor 张海娟
Owner BEIJING INST OF OPHTHALMOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products